IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS
Net Sales
Financial Review
Group sales rose 8.9% to $41,459 mil lion in 2008, with growth led by Pharmaceuticals, sup ported by
Vac cines and Di ag nos tics and Con sumer Health. Higher vol ume sales pro vided six per cent age points of
growth and cur rency ef fects added an other four per cent age points.
$ millions
45,000
40,000
35,000
30,000
25,000
20,000
15,000
10,000
5,000
0
Net Profit
Company Sales
2004 2005 2006 2007 2008
Source: Novartis January 2009/Novartis Annual Reports
Net profit in 2008 was $8,163 mil lion, up 24.8% from the fig ure for net profit from con tin u ing op er a tions
in 2007 of $6,540 mil lion. The net profit fig ure for 2007 was $11,968 mil lion with dis con tin ued op er a tions
(Gerber and Med i cal Nu tri tion) in cluded, and so net profit for 2008 com pared to this fig ure was down
31%. Net in come in 2008 was af fected by the fi nanc ing costs in July 2008 of Novartis’ ac qui si tion of 25%
of Alcon (USA).
$ millions
12,000
10,000
8,000
6,000
4,000
2,000
0
Net Profit
2004 2005 2006 2007 2008
Source: Novartis January 2009/Novartis Annual Reports
© 2009 IMS Health In cor po rated or its af fil i ates Page 16